期刊文献+

重楼复方对人胃癌细胞MKN-45增殖抑制作用及分子机制研究 被引量:6

Inhibitive Effect of Chonglou Recipe on Proliferation of Human Gastric Cancer Cell Line MKN-45 and Its Possible Molecular Mechanism
下载PDF
导出
摘要 目的研究重楼复方对人胃癌细胞株MKN-45增殖抑制作用,及其对细胞周期、细胞凋亡的影响,并探讨可能的分子机制。方法不同浓度的重楼复方作用于MKN-45细胞48 h后,采用四甲基偶氮唑蓝(MTT)显色法检测细胞增殖抑制率,采用流式细胞仪检测细胞凋亡及细胞周期,RT-PCR法检测凋亡相关基因Sur-vivin、c-IAP1、c-IAP2、Bcl-2 mRNA的表达。结果重楼复方以剂量依赖方式抑制人胃癌细胞株MKN-45的细胞增殖,其半数抑制浓度(IC50值)为0.67 mg.mL-1。重楼复方0.2,0.4,0.8 mg.mL-1作用于MKN-45细胞48h后,其早期凋亡率分别为7.0%、13.8%、36.3%,而对照组为3.4%,其诱导凋亡作用呈现剂量依赖性。重楼复方0.8 mg.mL-1作用于MKN-45细胞24 h后,细胞积聚在G0/G1期(对照组63.30%,重楼复方73.16%),同时S期细胞比例减少(对照组32.48%,重楼复方22.52%)。重楼复方0.8 mg.mL-1作用MKN-45细胞48 h后,Survivin、c-IAP1、c-IAP2、Bcl-2的mRNA水平均下调。结论重楼复方具有抑制人胃癌细胞株MKN-45增殖及诱导细胞凋亡作用,并能阻滞细胞于G0/G1期,下调Survivin、c-IAP1、c-IAP2、Bcl-2 mRNA的表达可能为其诱导细胞凋亡的主要机制之一。 Objective To investigate the effect of Chonglou Recipe(CP) on proliferation,cell cycle and aopotosis of human gastric cancer cell line MKN-45,and to explore the possible molecular mechanism.Methods After treating human gastric cancer cell line MKN-45 with CP at various concentrations(0.025~1.6 mg·mL-1) for 48 h,the proliferation rate of cell line MKN-45 was detected with methyl thiazolyl tetrazolium(MTT) method.The apoptosis and cell cycle phases were examined by flow cytometery(FCM).Reversed transcriptase polymerase chain reaction(RT-PCR) method was used to detect the mRNA expression of survivin,c-IAP1,c-IAP2 and Bcl-2.Results CP inhibited the proliferation of human gastric cancer cell line MKN-45 in a dose-dependent manner.The median effective concentration IC50 after incubation with CP for 48 hours was 0.67 mg·mL-1.After treatment with CP at the dosage of 0.2,0.4,and 0.8 mg·mL-1 for 48 hours,the apoptotic rate of cell line MKN-45 was 7.0 %,13.8 % and 36.3 %,respectively,showing a dose-dependent trend.The apoptotic rate was 3.4 % in the control group.After treatment with CP at the dosage of 0.8 mg·mL-1 for 24 h,the percentage of MKN-45 at G0/G1 phase was 73.16 %,and was 63.30 % in the control group,which was higher than the percentage of MKN-45 at S phase(22.52 % in CP group and 32.48 % in the control group).After MKN-45 cells were exposed to CP at the indicated concentration of 0.8 mg·mL-1 for 48 h,the mRNA expression of survivin,c-IAP1,c-IAP2 and Bcl-2 were down-regulated.Conclusion CP can inhibit the proliferation and induce apoptosis in human gastric carcinoma cell line MKN-45.Disturbing the cell cycle and down-regulating the mRNA expression of survivin,c-IAP1,c-IAP2 and Bcl-2 may be one of its therapeutic mechanisms.
出处 《中药新药与临床药理》 CAS CSCD 北大核心 2011年第3期258-262,共5页 Traditional Chinese Drug Research and Clinical Pharmacology
基金 南京市卫生局资助项目(YKK09095) 南京大学医学院附属鼓楼医院青年基金资助项目(2006004)
关键词 重楼复方 胃癌 凋亡 细胞周期 凋亡抑制因子 Chonglou Recipe Gastric cancer Apoptosis Cell cycle Survivin
  • 相关文献

参考文献1

二级参考文献47

  • 1Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985 [J]. Int J Cancer, 1993,54(4) :594-606.
  • 2Parkin DM, Bray FI, Devesa SS Cancer burden in the year 2000 [J] The global picture. Eur J Cancer, 2001,37(Suppl 8) : S4-S66.
  • 3Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce disparities in different geographic regions of the world [J]. J Clin Oncol, 2006,24(14) :2137-2150.
  • 4Pyrhonen S, Kuitunen T, Nyandoto P, et al. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer [J]. Br J Cancer,1995,71(3):587-591.
  • 5Murad AM, Santiago FF, Petroianu A, et al. Modified therapy with 5- fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer [J]. Cancer, 1993,72(1):37-41.
  • 6Schethauer W, Kornek G, Zeh B. Palliative chemotherapy vs supportive care in patients with metastatic gastric cancer: a randomized trial [C]. Second International Conference on Biology, Prevention and Treatment of Gastrointestinal malignancies. Koln, 1995 : 65.
  • 7Glimelius B, Ekstrom K, Hoffman K, et al. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer [J]. Ann Oncol, 1997, 8(2) : 163-168.
  • 8Wils JA, Klein HO, Wagener DJ, et al. Sequential high-dose methotrexate and fiuorouracil combined with doxorubicin-a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group [J]. J Clin Oncol, 1991,9(5): 827-831.
  • 9Webb A, Cunningham D, Scarffe JH, et al. Randomized trial comparing epirubicin, eisplatin, and fluorouraeil versus fluorouraeil, doxorubiein, and methotrexate in advanced esophagogastric cancer [J]. J Clin Oncol, 1997,15 ( 1 ) : 261-267.
  • 10Massuti B, Cervantes A, Aranda E, et al. A phase Ⅲ multicenter randomized trial in advanced gastric cancer: Fluorouracil +leucovorin + epirubicin + cisplatin (FLEP) vs Fluorouracilo + adriamycin+ methotrexate + leucovorin (FAMTX): response and survival [C]. Sixth International Congress on Anti- cancer Treatment, Paris, 1996.

共引文献97

同被引文献134

引证文献6

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部